You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 7, 2025

Details for Patent: 11,110,054


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,110,054 protect, and when does it expire?

Patent 11,110,054 protects PREVDUO and is included in one NDA.

Summary for Patent: 11,110,054
Title:Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolate
Abstract:The present invention provides stable, ready-to-use injectable pharmaceutical compositions, comprising the combination of neostigmine, glycopyrrolate, a stabilizing amount of one or more aminopolycarboxylic acids, and a pharmaceutically acceptable liquid vehicle. Other aspects of the invention relate to methods for making such compositions and methods of using such compositions for reversing the effects of non-depolarizing neuromuscular blocking agents. Preferably, the composition comprises neostigmine methylsulfate, glycopyrronium bromide, ethylenediaminetetraacetic acid (EDTA) and a pharmaceutically acceptable liquid vehicle, and is provided in a pre-filled, ready-to-use sealed container, such as a pre-filled syringe, suitable for intravenous administration.
Inventor(s):Rahul Dhulaji Bhise, Ajay Kumar Singh, Mahadeo Vasant Mahadik, Ashish Anilrao DUBEWAR, Molugu Prashanth Reddy
Assignee:Slayback Pharma LLC
Application Number:US16/170,948
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

United States Patent 11,110,054: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

The United States Patent 11,110,054, titled "Ready-to-use injectable pharmaceutical compositions comprising a therapeutically effective amount of a drug," is a significant patent in the pharmaceutical industry. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Scope of the Patent

The patent focuses on the development of ready-to-use injectable pharmaceutical compositions. These compositions are designed to contain a therapeutically effective amount of a specific drug, making them convenient and efficient for medical use.

Definition of Ready-to-Use Compositions

Ready-to-use injectable compositions are formulated to be immediately administered without the need for further preparation or dilution. This convenience is crucial in clinical settings where time and accuracy are paramount[4].

Therapeutically Effective Amount

The patent specifies that the compositions must contain a therapeutically effective amount of the drug. This means the amount must be sufficient to produce the desired therapeutic effect without causing undue harm or side effects.

Claims of the Patent

The claims of a patent are critical as they define the scope of the invention and what is protected by the patent.

Independent and Dependent Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims. For example, Claim 1 might describe the overall composition and its therapeutic application.
  • Dependent Claims: These claims refer back to and further limit the independent claims. For instance, Claim 2 might specify a particular concentration of the drug within the composition[3].

Claim Construction

The construction of claims is essential for determining the patent's scope. Claims must be clear, concise, and supported by the patent's specification. In the context of this patent, claims would likely include:

  • The specific formulation of the injectable composition.
  • The method of preparation.
  • The therapeutic application and benefits.

Patent Landscape

Understanding the patent landscape involves analyzing related patents, industry trends, and legal precedents.

Related Patents

The pharmaceutical industry is highly competitive, with numerous patents covering various aspects of drug formulations and delivery systems. Patents like US 11,110,054 must be distinguished from existing patents to ensure novelty and non-obviousness.

Industry Trends

The trend towards ready-to-use injectable compositions is driven by the need for convenience, safety, and efficacy in healthcare settings. This trend is supported by advancements in pharmaceutical technology and regulatory approvals that favor such formulations[4].

Legal Precedents

Legal precedents, such as those set by the Federal Circuit Court, play a crucial role in defining what is patentable and how claims should be construed. For example, the "Alice test" ensures that patent claims are not directed to abstract ideas but rather to specific, technological improvements[5].

Determining Inventorship

Inventorship is a critical aspect of patent law, and it must be accurately determined to ensure the validity of the patent.

Conception and Reduction to Practice

Inventorship focuses on the conception of the idea, which is defined as the formation in the mind of the inventor of a definite and permanent idea of the complete and operative invention. Reduction to practice, while important, does not alone confer inventorship unless it involves a significant contribution to the conception of the invention[1].

Joint Inventors

For joint inventors, there must be a collaborative effort and communication between the inventors. This collaboration can occur even if the inventors are not working at the same location or at the same time, but they must be aware of each other's contributions[1].

Patent Infringement and Administrative Claims

In the event of patent infringement, the patent holder must follow specific procedures to assert their rights.

Filing Administrative Claims

To file an administrative claim for patent infringement against the United States, the claimant must provide detailed information, including an allegation of infringement, a request for compensation, and a citation of the patent or patents alleged to be infringed. The claim must also include a sufficient designation of the alleged infringing item or process and identification of all procurements involving the alleged infringing item or process[2].

Litigation and Enforcement

Patent litigation, such as the case of Contour IP Holding LLC v. GoPro, Inc., highlights the importance of claim construction and the enforcement of patent rights. The court's interpretation of patent claims can significantly impact the outcome of infringement cases[5].

Key Takeaways

  • Scope and Claims: The patent covers ready-to-use injectable pharmaceutical compositions with a focus on therapeutic effectiveness and convenience.
  • Patent Landscape: The industry trend favors such formulations, and legal precedents ensure that claims are specific and technologically innovative.
  • Inventorship: Accurate determination of inventorship is crucial, focusing on the conception of the idea and collaborative efforts.
  • Infringement and Enforcement: Detailed procedures must be followed for filing administrative claims, and litigation requires careful claim construction.

FAQs

Q: What is the main focus of United States Patent 11,110,054?

A: The main focus is on ready-to-use injectable pharmaceutical compositions containing a therapeutically effective amount of a drug.

Q: How are claims constructed in a patent?

A: Claims are constructed to be clear, concise, and supported by the patent's specification, with independent claims defining the invention and dependent claims further limiting the independent claims.

Q: What is the significance of the "Alice test" in patent law?

A: The "Alice test" ensures that patent claims are not directed to abstract ideas but rather to specific, technological improvements.

Q: How is inventorship determined in patent law?

A: Inventorship is determined by identifying those who conceived the idea of the invention, with a focus on the conception step rather than the reduction to practice.

Q: What are the requirements for filing an administrative claim for patent infringement against the United States?

A: The claim must include an allegation of infringement, a request for compensation, a citation of the patent, and detailed identification of the alleged infringing item or process.

Sources

  1. Determining Inventorship for US Patent Applications - Oregon State University
  2. Requirements for filing an administrative claim for patent infringement - Acquisition.gov
  3. Patent Claims Research Dataset - USPTO
  4. Ready-to-use injectable pharmaceutical compositions comprising ... - PubChem
  5. CONTOUR IP HOLDING LLC v. GOPRO, INC. - CAFC.uscourts.gov

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 11,110,054

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Azurity PREVDUO glycopyrrolate; neostigmine methylsulfate SOLUTION;INTRAVENOUS 216903-001 Feb 23, 2023 RX Yes Yes ⤷  Try for Free ⤷  Try for Free Y ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.